期刊文献+

重组人生长激素对生长激素缺乏儿童脂代谢和脂联素水平的影响 被引量:5

Influence of Recombinant Human Growth Hormone on Lipid Metabolism and Adiponectin Levels in Children with Growth Hormone Deficiency
下载PDF
导出
摘要 目的研究重组人生长激素(rhGH)对生长激素缺乏症(GHD)患儿脂代谢和脂联素水平的影响。方法对53例GHD患儿及33例年龄、性别相匹配的正常对照儿童,及接受rhGH治疗时间达1年以上的23例GHD患儿检测血三酰甘油(TG)、总胆固醇(TC)、胰岛素样生长因子-1(IGF-1)和脂联素水平,比较GHD组与正常对照组及rhGH治疗前后血脂和脂联素水平变化。结果GHD患儿53例中高脂血症22例(41.5%),GHD与对照组血TG、TC分别为(1.6±1.6)vs(1.1±0.4)mmol/L、(4.5±0.8)vs(4.1±0.6)mmol/L,两组比较有显著差异(P均<0.05);经rhGH治疗后,GHD患儿TG、TC均明显下降,而IGF-1明显升高,治疗前后比较均有显著差异(P<0.01,0.05);治疗后脂联素水平略上升,但治疗前后比较无显著差异。多元回归分析显示,IGF-1与年龄呈正相关,与其他因素无关;脂联素与TG呈负相关。结论GH可能直接参与GHD患儿血脂的调节,脂联素可能部分参与TG的代谢。 Objective To study the influence of recombinant growth hormone(rhGH) on lipid metabolism and adiponectin(APN) levels of children with growth hormone deficiency(GHD). Methods Serum tryliceride(TG), total cholesteml(TC) ,insulin - like growth factor 1 ( IGF - 1 ), and APN levels were measured in 53 children with GHD[ 37 boys, 16 girls,aged (9.8 ±2.4) years old]range 5 - 15 years old, and 23 GHD children after rhGH replacement therapy, 33 healthy children matched by age and sex were recruited for comparisons, serum lipid profile and APN levels in children with GIID compared to controls and children over 1 year of replacement therapy with rhGH. Results Twenty - two of 53 children with Gill) had hyperlipidemia (41.5%), there was significant differences of serum TG levels [(1.6±1.6) vs (1.1±0.4) mmol/L,P〈0.05]and serum TC levels[(4.5±0.8) vs (4.1±0.6) mmol/L,P〈0.05] in children with GHD before treatment and that in normal children; after rhGH replacement therapy, serum TG and TC levels decreased significantly (P 〈 0.01,0.05 ), ,serum IGF-1 increased significantly (P〈 0.01 ) compared to pretreatment. APN levels showed a trend to increase after rhGH replacement therapy, but there was no significant difference (P = 0. 234). With regression analysis, IGF- 1 positively significantly correlated with age, not with other factors. APN levels was negatively correlated with TG. Conclusions rhGH replacement therapy significantly improves the lipid profile in GHD children, thus GH may directly take part in lipid profile controlling of GHD children. APN may partly take part in metabolism of TG.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2006年第20期1377-1378,1384,共3页 Journal of Applied Clinical Pediatrics
基金 浙江省医药卫生重点科技项目资助(2004ZD011)
关键词 重组人生长激素 脂代谢 脂联素 生长激素缺乏症 儿童 recombinant human growth hormone adiponectin lipid metabolism growth hormone deficiency child
  • 相关文献

参考文献12

  • 1赵正言,傅君芬.小儿内分泌疾病的诊治:儿科医师的新挑战[J].浙江大学学报(医学版),2005,34(4):287-292. 被引量:2
  • 2胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 3Hoffman AR,Kuntze JE,Baptista J,et al.Growth hormone (GH)replacement therapy in adult-onset GH deficiency:Effects on body composition in men and women in a double-blind,randomized,placebo-controlled trial[J].J Clin Endocrinol Metab,2004,89(5):2048-2056.
  • 4Boot AM,Engels MAMJ,Boerma GJM,et al.Changes in bone mineral density,body composition,and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency[J].J Clin Endocrinol Metab,1997,82(8):2423-2428.
  • 5Esposito V,Biase SDI,Lettiero T,et al.Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement[J].Clin Endocrinol,2004,61(5):607-611.
  • 6Lanes R,Paoli M,Carrillo E,et al.Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency:Relation to postprandial dyslipidemia[J].J Pediatr,2004,145(5):657-661.
  • 7Salerno M,Esposito V,Spinelli L,et al.Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy[J].Clin Endocrinol,2004,60 (5):630-636.
  • 8傅春江,王旭开,杨成明,王红勇,方玉强,石伟彬.重组生长激素对兔血脂及肝脏LDL受体mRNA的影响[J].第三军医大学学报,2005,27(8):753-755. 被引量:9
  • 9Diez JJ,Iglesias P.The role of the novel adipocyte-derived hormone adiponectin in human disease[J].Eur J Endocrinol,2003,148 (3):293-300.
  • 10Chan DC,Watts GF,Ng TW,et al.Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism[J].Clin Chem,2005,51 (3):578-585.

二级参考文献38

  • 1蒋优君,梁黎,邹朝春,傅君芬,李筠,洪芳,董关萍.简易戈那瑞林激发试验在真性性早熟诊断中的价值探讨[J].浙江大学学报(医学版),2004,33(5):452-455. 被引量:7
  • 2Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:436
  • 3陈肖肖,杨茹莱,施玉华,曹莉佩,周雪莲,毛华庆,赵正言.浙江省1999-2004年新生儿先天性甲状腺功能低下症筛查分析[J].浙江大学学报(医学版),2005,34(4):304-307. 被引量:22
  • 4De Boer H, Blok G J, Voerman H J, et al. Serum lipid levels in growth hormone-deficient men[J]. Metabolism, 1994, 43(2): 199-203.
  • 5Li Voon Chong J S, Benbow S, Foy P, et al. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects[J]. Clin endocrinol(Oxf), 2000, 53(5): 551-559.
  • 6Hassan H M, Kohno H, Kuromaru R, et al. Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment[ J].Acta Paediatr, 1996, 85(8): 899 - 901.
  • 7Weltman A, Despres J P, Clasey J L, et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults[J]. Metabolism, 2003, 52(1): 73-80.
  • 8Van Pareren Y K, De Muinck Keizer Schrana S M, Stijnen T, et al. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome[J]. J Clin Endocrinol Metab, 2002, 87(12): 5442-5448.
  • 9Florakis D, Hung V, Kaltsas G, et al. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study[J]. Clin Endocrinol (Oxf),2000, 53(4): 453-459.
  • 10l' Allemand D, Eiholzer U, Schlumpf M, et al. Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome[J]. Eur J Pediatr, 2000, 159( 11 ): 835 - 842.

共引文献402

同被引文献53

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部